• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国避孕方法选择实践推荐 2013:改编自世界卫生组织避孕方法选择实践推荐 2 版。

U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.

出版信息

MMWR Recomm Rep. 2013 Jun 21;62(RR-05):1-60.

PMID:23784109
Abstract

The U. S. Selected Practice Recommendations for Contraceptive Use 2013 (U.S. SPR), comprises recommendations that address a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. These recommendations are a companion document to the previously published CDC recommendations U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 (U.S. MEC). U.S. MEC describes who can use various methods of contraception, whereas this report describes how contraceptive methods can be used. CDC based these U.S. SPR guidelines on the global family planning guidance provided by the World Health Organization (WHO). Although many of the recommendations are the same as those provided by WHO, they have been adapted to be more specific to U.S. practices or have been modified because of new evidence. In addition, four new topics are addressed, including the effectiveness of female sterilization, extended use of combined hormonal methods and bleeding problems, starting regular contraception after use of emergency contraception, and determining when contraception is no longer needed. The recommendations in this report are intended to serve as a source of clinical guidance for health-care providers; health-care providers should always consider the individual clinical circumstances of each person seeking family planning services. This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health-care providers when considering family planning options.

摘要

美国 2013 年避孕选择实践推荐(U.S. SPR)包括针对特定常见但有时具有争议或复杂的问题的建议,这些问题涉及特定避孕方法的开始和使用。这些建议是之前发布的 CDC 避孕使用医学资格标准,2010 年(U.S. MEC)的配套文件。U.S. MEC 描述了谁可以使用各种避孕方法,而本报告则描述了如何使用这些避孕方法。CDC 根据世界卫生组织(WHO)提供的全球计划生育指导制定了这些 U.S. SPR 指南。虽然许多建议与 WHO 提供的建议相同,但它们已根据美国的实践进行了调整,以使其更加具体,或者因为新证据而进行了修改。此外,还涉及了四个新主题,包括女性绝育的效果、联合激素方法和出血问题的延长使用、在使用紧急避孕药后开始常规避孕,以及确定何时不再需要避孕。本报告中的建议旨在为医疗保健提供者提供临床指导的来源;医疗保健提供者在考虑计划生育方案时,应始终考虑每个寻求计划生育服务的人的个人临床情况。本报告无意替代针对个别患者的专业医疗建议。个人在考虑计划生育选择时应向其医疗保健提供者寻求建议。

相似文献

1
U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.美国避孕方法选择实践推荐 2013:改编自世界卫生组织避孕方法选择实践推荐 2 版。
MMWR Recomm Rep. 2013 Jun 21;62(RR-05):1-60.
2
U.S. Selected Practice Recommendations for Contraceptive Use, 2016.美国 2016 年避孕方法选择实践推荐
MMWR Recomm Rep. 2016 Jul 29;65(4):1-66. doi: 10.15585/mmwr.rr6504a1.
3
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.美国避孕方法医学适用标准,2016 年版。
MMWR Recomm Rep. 2016 Jul 29;65(3):1-103. doi: 10.15585/mmwr.rr6503a1.
4
U.S. Selected Practice Recommendations for Contraceptive Use, 2024.美国 2024 年避孕方法选择实践推荐
MMWR Recomm Rep. 2024 Aug 8;73(3):1-77. doi: 10.15585/mmwr.rr7303a1.
5
Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States.世界卫生组织避孕方法医学标准的适应调整,以用于美国。
Contraception. 2010 Jul;82(1):3-9. doi: 10.1016/j.contraception.2010.02.014. Epub 2010 Mar 29.
6
U S. Medical Eligibility Criteria for Contraceptive Use, 2010.美国避孕方法选择医学标准(2010)。
MMWR Recomm Rep. 2010 Jun 18;59(RR-4):1-86.
7
Adaptation of the World Health Organization's Selected Practice Recommendations for Contraceptive Use for the United States.适应世界卫生组织对美国选择的避孕使用实践建议。
Contraception. 2013 May;87(5):513-6. doi: 10.1016/j.contraception.2012.08.024. Epub 2012 Oct 4.
8
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.美国避孕方法医学适用标准,2024 年版。
MMWR Recomm Rep. 2024 Aug 8;73(4):1-126. doi: 10.15585/mmwr.rr7304a1.
9
Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection.美国避孕方法医学资格标准更新,2016 年:艾滋病毒感染高危妇女避孕方法使用的最新建议。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):405-410. doi: 10.15585/mmwr.mm6914a3.
10
U.S. selected practice recommendations for contraceptive use, 2013.美国 2013 年避孕方法选择实践建议
J Womens Health (Larchmt). 2014 Feb;23(2):108-11. doi: 10.1089/jwh.2013.4556. Epub 2013 Oct 11.

引用本文的文献

1
Case report: Uterine perforation caused by migration of intrauterine devices.病例报告:宫内节育器移位导致子宫穿孔
Front Med (Lausanne). 2024 Sep 5;11:1455207. doi: 10.3389/fmed.2024.1455207. eCollection 2024.
2
U.S. Selected Practice Recommendations for Contraceptive Use, 2024.美国 2024 年避孕方法选择实践推荐
MMWR Recomm Rep. 2024 Aug 8;73(3):1-77. doi: 10.15585/mmwr.rr7303a1.
3
Early intrauterine pregnancy with an intrauterine device in place and terminated with spontaneous abortion: A case report.带器宫内妊娠早期自然流产 1 例报告。
Medicine (Baltimore). 2024 Apr 19;103(16):e37843. doi: 10.1097/MD.0000000000037843.
4
Hormonal steroids induce multidrug resistance and stress response genes in Neisseria gonorrhoeae by binding to MtrR.激素类固醇通过与 MtrR 结合诱导淋病奈瑟菌中的多药耐药和应激反应基因。
Nat Commun. 2024 Feb 7;15(1):1153. doi: 10.1038/s41467-024-45195-1.
5
A 3-year Retrospective Review of Contraceptive Initiation, Continuation, Switching, and Pregnancy Among Adolescents and Young Adults.青少年和青年人群避孕措施的开始、持续、转换及妊娠情况的3年回顾性研究
J Adolesc Health. 2024 Apr;74(4):794-800. doi: 10.1016/j.jadohealth.2023.11.010. Epub 2023 Dec 14.
6
Expanding community pharmacists' scope of practice in relation to contraceptive counselling and referral: a protocol for a pragmatic, stepped-wedge, cluster randomised trial (ALLIANCE).扩大社区药剂师在避孕咨询和转介方面的执业范围:一项实用、阶梯式、整群随机试验的方案(ALLIANCE)。
BMJ Open. 2023 Aug 31;13(8):e073154. doi: 10.1136/bmjopen-2023-073154.
7
Pregnancy in Patients with Pulmonary Arterial Hypertension in Light of New ESC Guidelines on Pulmonary Hypertension.根据新的 ESC 肺动脉高压指南看肺动脉高压患者的妊娠问题。
Int J Environ Res Public Health. 2023 Mar 6;20(5):4625. doi: 10.3390/ijerph20054625.
8
Neglected Intrauterine Device Migration Complications: Case Reports.被忽视的宫内节育器移位并发症:病例报告
Womens Health Rep (New Rochelle). 2023 Jan 18;4(1):11-18. doi: 10.1089/whr.2022.0099. eCollection 2023.
9
Recent Intimate Partner Violence and Oral Contraceptive Pill Adherence in a Cohort of Reproductive-Aged Women.近期亲密伴侣暴力与育龄期女性口服避孕药依从性的队列研究。
J Womens Health (Larchmt). 2022 Dec;31(12):1703-1709. doi: 10.1089/jwh.2021.0622. Epub 2022 Sep 20.
10
Incorporating Black women's perspectives into long-acting reversible contraception implementation.将黑人女性的观点纳入长效可逆避孕措施的实施过程中。
F S Rep. 2022 Feb 23;3(2 Suppl):80-90. doi: 10.1016/j.xfre.2022.02.005. eCollection 2022 May.